Pharmacies looking to shed the burden of manual, repetitive work just got a boost, as TJM Labs, an AI-driven automation specialist, announced it has raised $75.0M in Series b funding. The capital infusion, backed by investor Elephant, will support TJM Labs' efforts to streamline operations like prescription intake, fax processing, and demographic updates within existing pharmacy systems.
The company sets itself apart with a Dual-Expert Model™, deploying both pharmacists and engineers to tailor its AI solutions for clinical accuracy and technical precision. This hands-on approach helps pharmacies process tens of thousands of prescriptions weekly, delivering measurable ROI through lower costs and fewer errors, ultimately freeing staff to focus on patient care.
